Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA) (2015)
- Authors:
- USP affiliated authors: TAVARES, LEOBERTO COSTA - FCF ; STORPIRTIS, SILVIA - FCF
- Unidade: FCF
- DOI: 10.3109/03639045.2014.925919
- Subjects: ANTI-INFECCIOSOS; BIOFARMÁCIA; RESISTÊNCIA MICROBIANA ÀS DROGAS; STAPHYLOCOCCUS
- Language: Inglês
- Imprenta:
- Source:
- Título: Drug Development and Industrial Pharmacy
- ISSN: 0363-9045
- Volume/Número/Paginação/Ano: v. 41, n. 7, p. 1066-1072
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão submetida (Pré-print)
-
Status: Artigo possui versão em acesso aberto em repositório (Green Open Access) -
ABNT
FERNANDES, Mariane Ballerini et al. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA). Drug Development and Industrial Pharmacy, v. 41, n. 7, p. 1066-1072, 2015Tradução . . Disponível em: https://doi.org/10.3109/03639045.2014.925919. Acesso em: 15 mar. 2026. -
APA
Fernandes, M. B., Gonçalves, J. E., Tavares, L. C., & Storpirtis, S. (2015). Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA). Drug Development and Industrial Pharmacy, 41( 7), 1066-1072. doi:10.3109/03639045.2014.925919 -
NLM
Fernandes MB, Gonçalves JE, Tavares LC, Storpirtis S. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA) [Internet]. Drug Development and Industrial Pharmacy. 2015 ; 41( 7): 1066-1072.[citado 2026 mar. 15 ] Available from: https://doi.org/10.3109/03639045.2014.925919 -
Vancouver
Fernandes MB, Gonçalves JE, Tavares LC, Storpirtis S. Caco-2 cells permeability evaluation of nifuroxazide derivatives with potential activity against methicillin-resistant Staphylococcus aureus (MRSA) [Internet]. Drug Development and Industrial Pharmacy. 2015 ; 41( 7): 1066-1072.[citado 2026 mar. 15 ] Available from: https://doi.org/10.3109/03639045.2014.925919 - Development and validation of an analytical method for the quantification of a new nifuroxazide furanic amino-substituted derivative in caco-2 cells permeability studies
- Determination by high performance liquid chromatography (HPLC) of a low permeability model drug used in Caco-2 cells studies
- Development and validation of an analytical method for nifuroxazide quantification in caco-2 cells permeability studies
- Development and validation of analytical method for nitrofurantoin quantification in CACO-2 cells permeability studies
- Previsão da permeabilidade in vitro de derivados da nifuroxazida com atividade frente a cepas multirresistentes de S. aureus (MRSA)
- Caco-2 cells cytotoxicity of nifuroxazide derivatives with potential activity against Methicillin-resistant Staphylococcus aureus
- Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents
- Planejamento, síntese e avaliação da bioatividade de compostos nitro-heterocíclicos com potencial ação frente ao Trypanosoma cruzi
- Design, synthesis and antimicrobial activity of 5-nitro-furfuryliden derivatives against nosocomial pathogens
- 5-nitro-2-furfurylidene compounds with activity against multidrug-resistant microorganisms
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
